Thermogenesis Holdings IncNASDAQ:THMONASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6626
- TODAY'S CHANGE (%)0.0126 (1.9385%)
- Bid / Lots0.4600/ 1
- Ask / Lots0.7200/ 1
- Open / Previous Close0.6510 / 0.6500
- Day Range
- 52 Week Range
- Volume8,586
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | THMO |
|---|---|---|
| 09:32 ET | 111 | 0.651 |
| 10:35 ET | 200 | 0.6837 |
| 10:37 ET | 100 | 0.719 |
| 11:22 ET | 2300 | 0.6202 |
| 11:56 ET | 100 | 0.6999 |
| 12:16 ET | 433 | 0.64 |
| 12:54 ET | 569 | 0.699 |
| 01:12 ET | 2350 | 0.6401 |
| 01:28 ET | 100 | 0.699 |
| 01:35 ET | 1419 | 0.66 |
| 01:50 ET | 100 | 0.6626 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Thermogenesis Holdings Inc | 5.2M | -0.1x | --- |
Global Payment Technologies Inc | 10.0 | 0.0x | --- |
Saguaro Holdings Corp | 16.0K | 0.0x | --- |
Electro Optical Systems Corp | 2.1K | 0.0x | --- |
Voxeljet AG | 5.4M | -0.5x | --- |
IncJet Holding Inc | 12.1M | 22.7x | --- |
Company Information
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. It provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.
Contact Information
- Headquarters
- 2711 Citrus RdRANCHO CORDOVA, CA, United States 95742-6228
- Phone
- 916-858-5100
- Fax
- 916-858-5199
Executives
- Chairman of the Board, President, Chief Executive Officer
- Xiaochun Xu
- Chief Financial Officer
- Jeffery Cauble
- Chief Operating Officer
- Haihong Zhu
- Independent Director
- Russell Medford
- Independent Director
- Joseph Thomis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.2M |
|---|---|
Revenue (TTM) | $9.7M |
Shares Outstanding | 8.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.41 |
EPS | $-10.11 |
Book Value | $4.14 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -63.66% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
